English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
A 7-methoxybicoumarin derivative selectively inhibits BRD4 BD2 for anti-melanoma therapy Journal article
Yang,Guan Jun, Wang,Wanhe, Lei,Pui Man, Leung,Chung Hang, Ma,Dik Lung. A 7-methoxybicoumarin derivative selectively inhibits BRD4 BD2 for anti-melanoma therapy[J]. International Journal of Biological Macromolecules, 2020, 164, 3204-3220.
Authors:  Yang,Guan Jun;  Wang,Wanhe;  Lei,Pui Man;  Leung,Chung Hang;  Ma,Dik Lung
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:7.7/7.7 | Submit date：2021/03/01
Brd4  BromoDomain Domain  Cell Metastasis And Invasion  Histone Acetylation  Melanoma  Protein–protein Interaction  Virtual Screening  
Nanoparticle-based drug delivery systems for targeted epigenetics cancer therapy Review article
2020
Authors:  Chen, Fengqian;  Shi, Yunzhen;  Zhang, Jinming;  Liu, Qi
Favorite | TC[WOS]:8 TC[Scopus]:13  IF:3.0/3.3 | Submit date：2023/04/19
Bromodomain  Dna Methylation  Epigenetic Regulation/pathway/change  Gene Expression  Histone Modifications/methylation/ Acetylation  Nanoparticle/nanomedicine/nanotechnology  Non-coding Rna  
Selective targeting of BRCA1 deficient breast cancer by bromodomain and extra-terminal motif (BET) inhibitors Conference paper
Zhang, B., Yang, E. J., Lyu, J., Liu, Y., Wu, C., Chen, Q., Tan, K., Wong, K. H., Xu, X., Deng, C., Shim, J. S.. Selective targeting of BRCA1 deficient breast cancer by bromodomain and extra-terminal motif (BET) inhibitors[C], 2017.
Authors:  Zhang, B.;  Yang, E. J.;  Lyu, J.;  Liu, Y.;  Wu, C.; et al.
Favorite |  | Submit date：2022/07/27
Bromodomain and extra-terminal motif  BRCA1  synthetic lethality